Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06268574 |
| Consolidated Lead Sponsor | Ryvu Therapeutics SA |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 62 participants (ACTUAL) |
| Registered Start Date | 2024-01-23 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| ASST Grande Ospedale Metropolitano Niguarda | Milan, Italy | Open Hospital Dossier -> |
| Azienda Ospedaliero Universitaria Pisana | Pisa, Italy | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.